Stockholm (HedgeNordic) – Brummer & Partners last year created a new structure called “PM pods” to onboard new managers that run dedicated investment mandates exclusively for its multi-strategy vehicle Brummer Multi-Strategy (BMS). After recruiting technology-focused portfolio manager Henrik Nyblom from Swedbank Robur Ny Teknik to run the first pod, Brummer & Partners has now announced the recruitment of Hans Mähler to run the second pod, a healthcare-focused segregated mandate within BMS.
Initially solely available for investors in Brummer Multi-Strategy, the mandate is expected to launch during the fourth quarter of 2022. Assisted by newly-hired analyst Carl Mellerby, Hans Mähler will employ a healthcare-focused market-neutral strategy, taking long and short positions in healthcare companies primarily in Europe and the United States. Mähler most recently worked at Philips as Director – Strategy, M&A and Partnerships, and has 22 years of experience working within and analyzing the healthcare sector. Before Philips, Mähler was Director of Equity Research Healthcare at Nordea Markets, as well as a healthcare-focused equity analyst at Handelsbanken Capital Markets and DNB Markets.
“Healthcare is a complex sector characterized by high levels of innovation and volatility. In my opinion, the ability to take both long and short positions will be critical to succeed going forward.”
“Healthcare is a complex sector characterized by high levels of innovation and volatility. In my opinion, the ability to take both long and short positions will be critical to succeed going forward,” says Hans Mähler, the strategy’s portfolio manager. Mähler will be joined by analyst Carl Mellerby, who most recently served as a senior equity analyst at SEB. Brummer Multi-Strategy, which is up 4.5 percent in SEK year-to-date through mid-April, is expected to have an initial allocation of around $200 million to the new investment mandate.
“We have been searching for quite some time now for a healthcare-focused market-neutral long/short equity strategy. We believe that this is an area where there will be many winners and losers going forward.”
“We have been searching for quite some time now for a healthcare-focused market-neutral long/short equity strategy. We believe that this is an area where there will be many winners and losers going forward,” comments Kerim Celebi (pictured), portfolio manager of BMS. “Hans Mähler has extensive experience from the sector and the right skill set to generate alpha across a wide range of market scenarios,” he continues. “With his investment mandate, initially exclusive to BMS investors, Hans and his team will further improve the diversification in BMS’s portfolio.”
